ArticleActa diabetologica2026
A TFAP4-UBC9-SUMO1 axis orchestrates pathological mitochondrial hyperfission in diabetic complications.
Article in Acta diabetologica, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundMitochondrial failure is a cornerstone of diabetic organ damage. While it is well understood that shattered mitochondria (excessive fission) and aggressive cleanup (mitophagy) drive this deterioration, the upstream genetic "switches" that trigger these processes remain unclear. This study investigates whether a specific regulatory chain the TFAP4-UBC9-SUMO1 axis orchestrates this mitochondrial breakdown in diabetic tissues.
methodsWe analyzed transcriptomic data from four independent cohorts (GEO datasets: GSE1009, GSE4745, GSE6880, and GSE133598) covering diabetic renal and cardiac tissues. By integrating differential expression analysis with functional enrichment tools (GO, KEGG, and GSEA), we mapped the molecular landscape connecting cellular stress to mitochondrial dynamics and metabolic remodeling.
resultsOur analysis revealed a synchronized stress response across all datasets rather than isolated gene changes. Diabetic tissues exhibited a distinct upregulation of pathways related to protein SUMOylation, mitochondrial organization, and ER stress. Specifically, the data showed a convergence of signals indicating chronic "Protein processing in the endoplasmic reticulum" and sustained "Mitophagy," accompanied by broad shifts in lipid and energy metabolism. These signatures suggest that the machinery responsible for SUMO-modifying proteins is hyperactive and tightly linked to mitochondrial clearance programs.
conclusionThe transcriptomic evidence supports a model where TFAP4 acts as a transcriptional driver that boosts UBC9 and SUMO1 expression. This upregulation likely fuels the SUMO-dependent modification of DRP1, locking mitochondria in a state of hyper-fission and forcing the cell into excessive self-eating (mitophagy). The TFAP4-UBC9-SUMO1 axis thus represents a critical, yet overlooked, engine of mitochondrial depletion and offers a promising new target for halting diabetic complications.
Indexed as
Identifiers
41603949What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.